The phase 1 is in a way agnostic for the indication I believe as at that stage they are dosing healthy individuals to check safety and tolerability. As you say it would be about dosage and the level they would want to go in would be calculated from the animal preclinical work done.
Share Price, page-9996
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.36 |
Change
-0.630(3.15%) |
Mkt cap ! $2.483B | |||
| Open | High | Low | Value | Volume |
| $20.10 | $20.10 | $19.30 | $5.622M | 288.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 228 | $19.34 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.36 | 173 | 8 |
View Market Depth
| Last trade - 15.03pm 09/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |